2. Others

Others

Others

Related Products

PDF 58.49 MB

There are a number of inhibitors, agonists, and antagonists which we cannot make precise classification because the research area is still unknown.

Others Related Products (73787):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-185558
    N-Methylthalidomide-Pip-NHBoc 3061315-50-9 98%
    N-Methylthalidomide-Pip-NHBoc is an E3 ligase ligand-linker conjugate that incorporates the CRBN ligand and a linker. N-Methylthalidomide-Pip-NHBoc can be used to synthesize LLC0424N (HY-185557) .
    N-Methylthalidomide-Pip-NHBoc
  • HY-185564
    F6OM 118680-70-9 98%
    F6OM, a nonionic fluorinated octyl maltoside derivative, is a surfactant. F6OM readily interacts with and completely solubilizes phospholipid vesicles via a heterogeneous solubilization mechanism, without compromising membrane order at subsolubilizing concentrations. F6OM promotes bilayer insertion of an integral membrane enzyme in the absence of micelles to support functional refolding of integral membrane proteins. F6OM can be used for membrane-protein applications.
    F6OM
  • HY-185575
    ATM ligand-1 3056059-49-2
    ATM ligand-1 is an ATM ligand that can be used for the synthesis of PROTACs, such as PROTAC ATM degrader-1 (HY-158345).
    ATM ligand-1
  • HY-185587
    Anionic Liposomes (DOPG:DOPC (90:10 molar ratio, 10mM))
    Anionic Liposomes (DOPG:DOPC (90:10 molar ratio, 10 mM)) is a type of artificial lipid vesicle with strong negative charge (Liposome), composed of 90% DOPG (HY-142980) and 10% DOPC. DOPG is a phosphatidylglycerol composed of unsaturated fatty acids (oleoyl groups), providing negative charges and membrane fluidity. DOPC acts as a neutral matrix lipid, mainly used to maintain the integrity and appropriate fluidity of the lipid bilayer, and does not change the net charge itself.
    Anionic Liposomes (DOPG:DOPC (90:10 molar ratio, 10mM))
  • HY-185588
    Anionic Liposomes (DOPG, 10mM)
    Anionic Liposomes (DOPG, 10mM) is a Phosphatidylglycerol (PG)-based-100% DOPG formulation. Anionic Liposomes (DOPG, 10mM) can be used for drug delivery and lipid-protein interactions.
    Anionic Liposomes (DOPG, 10mM)
  • HY-185594
    4-(Cyclohexylbuta-1,3-diyn-1-yl)benzoic acid
    4-(Cyclohexylbuta-1,3-diyn-1-yl)benzoic acid is a Hyt hydrophobic group. 4-(Cyclohexylbuta-1,3-diyn-1-yl)benzoic acid can be used in the synthesis of PARP1 degrader 1 (HY-180276).
    4-(Cyclohexylbuta-1,3-diyn-1-yl)benzoic acid
  • HY-185595
    N,3-BisBoc-L-Histidine 77205-61-9
    N,3-BisBoc-L-Histidine is a Hyt hydrophobic group. N,3-BisBoc-L-Histidine can be used in the synthesis of BCR-ABL degrader 1 (HY-180798).
    N,3-BisBoc-L-Histidine
  • HY-185660
    ST41 2136331-91-2
    ST41 is a conjugate compound having three saccharide ligands and modified phosphate groups within the saccharide portion. ST41 can be used for nucleotide modification and targeted delivery.
    ST41
  • HY-185668
    2',5'-Dideoxy-3'-ATP 162554-02-1
    2',5'-Dideoxy-3'-ATP is an adenylate cyclase inhibitor. 2',5'-Dideoxy-3'-ATP exerts linear noncompetitive inhibition via binding to the distinct P-site. 2',5'-Dideoxy-3'-ATP binds and stabilizes the dimeric form of Mycobacterium avium adenylyl cyclase Ma1120 to inhibit activity.
    2',5'-Dideoxy-3'-ATP
  • HY-185679
    W19-LNP 2991244-19-8
    W19-LNP is a lipid nanoparticle formulated with a Ugi-reaction-derived ionizable lipid (W19). W19-LNP demonstrates highly selective mRNA delivery to the spleen in female BALB/c mice upon intravenous administration. W19-LNP can be used for the research of mRNA-based vaccine delivery, immune cell reprogramming, and gene-engineered cell preparation.
    W19-LNP
  • HY-185692
    Ac-Cys-Deruxtecan 2409510-92-3
    Ac-Cys-Deruxtecan is a drug linker intermediate used in antibody-drug conjugate manufacturing.Ac-Cys-Deruxtecan reacts with reduced antibodies, and excess unreacted forms are quenched by thiol-containing reagents.
    Ac-Cys-Deruxtecan
  • HY-185693
    DBCO2-PEG24 98%
    DBCO2-PEG24 is a non-targeting bivalent DBCO-functionalized shielding agent with a PEG24 spacer, which can be used as a surface shielding control. DBCO2-PEG24 binds to the surface of lipid oligomer-modified siRNA lipopolymer nanoparticles via copper-free click reaction (SPAAC).
    DBCO2-PEG24
  • HY-185698
    IRF4 ligand-1 3113827-15-6 98%
    IRF4 ligand-1 is an IRF4 ligand that can be used for the synthesis of PROTACs, such as dIRF4-2 (HY-185697).
    IRF4 ligand-1
  • HY-18570R
    1-Naphthaleneacetic acid (Standard) 86-87-3 98%
    1-Naphthaleneacetic acid (Standard) is the analytical standard of 1-Naphthaleneacetic acid. This product is intended for research and analytical applications. 1-Naphthaleneacetic acid (1-Naphthylacetic acid), a auxin, can promote plant growth. 1-Naphthaleneacetic acid is also an inhibitor of PLA2, with an IC50 of 13.16 μM.
    1-Naphthaleneacetic acid (Standard)
  • HY-185761
    ADC Control Human IgG1-rezetecan
    ADC Control Human IgG1-rezetecan is an isotype-matched control antibody-drug conjugate (ADC) for Mocertatug rezetecan (HY-185280). Mocertatug rezetecan is an ADC targeting B7-H4.
    ADC Control Human IgG1-rezetecan
  • HY-186047
    ETE-S trimer 2064006-29-5 98%
    ETE-S trimer is a conjugated trimer that undergoes polymerization under the action of plant cell wall peroxidases, forming an ion-electron hybrid conductive polymer suitable for bio-hybrid supercapacitors.
    ETE-S trimer
  • HY-186077
    PEDA 247096-81-7
    PEDA is a chemical intermediate. PEDA can participate in the CuAAC reaction to synthesize ethylenediamine analogs including Biot-EDA, Cy3-EDA, EDA-AG and EDA-m7Gp3G, which are used for RNA modification.
    PEDA
  • HY-186088
    DOTA-tris(t-Bu)ester-PEG3-C2-amine 3078821-76-5
    DOTA-tris (t-Bu) ester-PEG3-C2-amine (Compound 9) is a conjugate of DOTA-based chelator and linker, bearing tris (t-Bu) ester and PEG3-C2-amine functional groups. DOTA-tris (t-Bu) ester-PEG3-C2-amine can be conjugated to payloads via bioorthogonal click chemistry for targeted delivery.
    DOTA-tris(t-Bu)ester-PEG3-C2-amine
  • HY-186090
    4-Hydroxy-L-arginine 61370-10-3 98%
    4-Hydroxy-L-arginine is a arginine derivative.
    4-Hydroxy-L-arginine
  • HY-186093
    (S,S)-Reboxetine-OH 252570-31-3
    (S,S)-Reboxetine-OH is a phenol compound. (S,S)-Reboxetine-OH can be used to synthesize norepinephrine transporter ligand.
    (S,S)-Reboxetine-OH